Long-term survival in multiresistant metastatic choriocarcinoma after pembrolizumab treatment: A case report.

Authors :: Paspalj V
Polterauer S
Poetsch N
Reinthaller A
Grimm C
Bartl T
Source :: Gynecologic oncology reports [Gynecol Oncol Rep] 2021 Jun 24; Vol. 37, pp. 100817. Date of Electronic Publication: 2021 Jun 24 (Print Publication: 2021).
Publication Year :: 2021
Abstract: •Checkpoint inhibitor therapy affecting PD-L1 as treatment for advanced solid tumors.•Success in trial pembrolizumab therapy in multiresistant metastatic choriocarcinoma.•Long-term remission after pembrolizumab therapy in multiresistant choriocarcinoma.•Only six reported cases, one with comparable follow-up and outcome.<br />Competing Interests: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.<br /> (© 2021 The Authors. Published by Elsevier Inc.)

Full Text Access

Tools